Finance

Lists
Why is 307280 up 5.35%?
Dive Deeper
307280:KOSDAQ
Wonbiogen Co Ltd
₩5,510.00
+5.35%
(+280.00) 1D
Nov 13, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 307280...
Open
₩5,230
High
₩5,670
Low
₩5,170
Mkt. cap
39.09B
Avg. vol.
12.28K
Volume
0.00
Dividend
2.54%
Quarterly dividend
₩35
Ex-dividend date
Dec 29, 2026
P/E ratio
4.56
52-wk high
₩8,400
52-wk low
₩4,950
EPS
₩1,207
Shares outstanding
7.09M
No. of employees
81
Open
₩5,230
High
₩5,670
Low
₩5,170
Mkt. cap
39.09B
Avg. vol.
12.28K
Volume
0.00
Dividend
2.54%
Quarterly dividend
₩35
Ex-dividend date
Dec 29, 2026
P/E ratio
4.56
52-wk high
₩8,400
52-wk low
₩4,950
EPS
₩1,207
Shares outstanding
7.09M
No. of employees
81
News stories
From web sources and news partners
About Wonbiogen Co Ltd
CEO-
Employees81
Founded2006
Headquarters-
SectorHealth Care
IndustryMedical device
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
9.22B
9.37B
9.28B
9.93B
Cost of goods sold
4.32B
4.56B
4.65B
4.71B
Cost of revenue
4.32B
4.56B
4.65B
4.71B
Research and development expenses
222.11M
214.66M
220.67M
173.61M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.17B
2.27B
2.16B
1.95B
Operating expense
2.34B
2.65B
2.46B
2.49B
Total operating expenses
6.66B
7.21B
7.11B
7.20B
Operating income
2.55B
2.17B
2.17B
2.73B
Other non operating income
56.00M
-32.04M
1.52M
695.51M
EBT including unusual items
2.66B
1.80B
2.28B
3.33B
EBT excluding unusual items
2.72B
2.12B
2.28B
3.49B
Income tax expense
445.32M
256.13M
416.45M
531.67M
Effective tax rate
16.74%
14.22%
18.29%
15.95%
Other operating expenses
10.90M
15.81M
7.64M
18.91M
Net income
2.18B
1.59B
1.67B
2.99B
Net profit margin
23.63%
16.96%
17.99%
30.06%
Earnings per share
-
-
-
-
Interest and investment income
71.70M
67.38M
59.37M
60.87M
Interest expense
-9.80M
-7.37M
-14.68M
-19.98M
Net interest expenses
61.91M
60.02M
44.69M
40.89M
Depreciation and amortization charges
103.79M
109.68M
145.33M
137.73M
EBITDA
2.92B
2.54B
2.57B
3.13B
Gain or loss from assets sale
59.48M
64.99M
1.14M
-
Upcoming events
AI content may include mistakes. Learn more
Google apps